Outsourced Pharma Services 2021

Download PDF
  • Contract Research Organisations (CROs)

    CROs are constantly expanding their addressable markets by broadening their service offerings, capturing an increasing share of pharma R&D expenditure. Investment in technology and big data will continue to play an important role in the expansion of the CRO sub-sector.

    Læs mere…
  • Contract Development and Manufacturing Market (CDMOs)

    As innovator pipelines have deepened and the complexities of developing and manufacturing more recent generations of pharma (including biologics) have increased, the need to simplify manufacturing operations and reduce operating expenditure has led to the emergence of the CDMO industry.

    Læs mere…